SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017554
Filing Date
2022-11-14
Accepted
2022-11-14 07:07:43
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20220930x10q.htm   iXBRL 10-Q 1014201
2 EX-10.1 plx-20220930xex10d1.htm EX-10.1 565729
3 EX-10.2 plx-20220930xex10d2.htm EX-10.2 57473
4 EX-31.1 plx-20220930xex31d1.htm EX-31.1 10033
5 EX-31.2 plx-20220930xex31d2.htm EX-31.2 10393
6 EX-32.1 plx-20220930xex32d1.htm EX-32.1 6131
7 EX-32.2 plx-20220930xex32d2.htm EX-32.2 6157
8 GRAPHIC plx-20220930x10q005.jpg GRAPHIC 113571
9 GRAPHIC plx-20220930x10q006.jpg GRAPHIC 100730
10 GRAPHIC plx-20220930x10q007.jpg GRAPHIC 35810
  Complete submission text file 0001558370-22-017554.txt   4990558

Data Files

Seq Description Document Type Size
11 EX-101.SCH plx-20220930.xsd EX-101.SCH 30108
12 EX-101.CAL plx-20220930_cal.xml EX-101.CAL 35257
13 EX-101.DEF plx-20220930_def.xml EX-101.DEF 127889
14 EX-101.LAB plx-20220930_lab.xml EX-101.LAB 222057
15 EX-101.PRE plx-20220930_pre.xml EX-101.PRE 198750
43 EXTRACTED XBRL INSTANCE DOCUMENT plx-20220930x10q_htm.xml XML 435473
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 221380125
SIC: 2836 Biological Products, (No Diagnostic Substances)